NEW YORK (GenomeWeb) – Following completion of a validation study, German prenatal genetic testing provider LifeCodexx plans to launch a new noninvasive prenatal fetal trisomy test that is based on methylation-specific quantitative PCR.

The new test, called qNIPT, will become available "as soon as possible," LifeCodexx CEO Michael Lutz told GenomeWeb. It will initially only detect fetal trisomy 21 but is expected to cover other fetal trisomies in the future.